GlassScriptPhysician profile
Michelle Morris
NPI 1891189015
$3,103.22
in general payments reported to CMS, 2019-2025
15 companies · $2,220 in 2025
The $2,220 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.60 · 2024: $819 · 2025: $2,220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,039.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,038.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $737.23 | 2024-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $599.17 | 2024-2025 | Ozempic, Wegovy, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $378.74 | 2024-2025 | |
| Amgen INC. | $345.95 | 2024-2025 | Repatha, Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $320.52 | 2024-2025 | Jardiance |
| Glaxosmithkline, LLC. | $198.44 | 2024-2025 | Trelegy Ellipta, Arexvy |
| Dexcom, INC. | $148.21 | 2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor |
| Astellas Pharma US INC | $64.60 | 2019 | |
| Shield Therapeutics INC | $60.81 | 2025 | |
| Lilly USA, LLC | $60.53 | 2024-2025 | Zepbound, Mounjaro |
| Exact Sciences Corporation | $58.41 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Esperion Therapeutics, INC. | $45.08 | 2024 | Nexletol |
| Baxter Healthcare | $34.43 | 2025 | Hillrom - Retinavue 700 Imager |
| Mannkind Corporation | $28.37 | 2024 | |
| Corcept Therapeutics | $22.73 | 2025 | Korlym |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.